In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 58 for your search:
Drug:  idarubicin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1586

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI, Other
Protocol IDs: CDR0000063574, MDA-DM-94017, NCI-T94-0040D, DM94-017, T94-0040, NCT00002565

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: at least 1 + under 20 at diag.
Sponsor: NCI
Protocol IDs: CCG-1941

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 22
Sponsor: NCI
Protocol IDs: NCI-2012-01834, 2961, U10CA098543, CDR0000064883, COG-2961, CCG-2961, NCT00002798

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: 1961, CCG-1961, CDR0000064953, NCT00002812

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI, Other
Protocol IDs: 1951, CCG-1951, CDR0000064968, NCT00002816

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 59
Sponsor: NCI, Other
Protocol IDs: MDA DM95-121, P30CA016672, NCI-V96-1010, CDR0000065044, NCT00002835

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000065146, MRC-LEUK-CML-2000, ECOG-E7995, MRC-LEUK-CML-IV, MRC-LEUK-CML-IVa, EU-96029, E7995, NCT00002868

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 55
Sponsor: NCI
Protocol IDs: E-3489, CLB-9120, SWOG-9034, EST-3489, E3489

11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: CCG-1884

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 25
Sponsor: NCI
Protocol IDs: RPMI-DS-9120, NCI-T91-0125D, T91-0125

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: at least 56
Sponsor: NCI
Protocol IDs: E-3993, EST-4-09, E3993

14.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 2 to 21
Sponsor: NCI
Protocol IDs: COG-AAML0631, COG-AAML0631, AAML0631, NCT00866918

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 15 to 70
Sponsor: NCI
Protocol IDs: NCI-2012-02862, 2003-0563, 6625, N01CM62202, MDA-2003-0563, NCI-6625, NCT00096122

16.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 1 to 30
Sponsor: NCI, Other
Protocol IDs: AAML06P1, CDR0000543398, COG-AAML06P1, NCT00469859

17.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: 12393, NCI-2013-01141, NCT01876953

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 12 and over
Sponsor: NCI
Protocol IDs: MSKCC-94088A3, NCI-H94-0571, NCT00002609

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: not over 21
Sponsor: NCI
Protocol IDs: CCG-2941

20.

Phase: Phase II
Type: Treatment
Status: Closed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9411

21.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 65 and under
Sponsor: NCI
Protocol IDs: FHCRC-964.00, NCI-V96-0921

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-96044, NCI-V96-0941, NCT00002800

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 55 to 70
Sponsor: NCI, Other
Protocol IDs: DM94-078, P30CA016672, MDA-DM-94078, NCI-G96-1001, CDR0000065035, NCT00002833

24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-96071, NU-K96H2, NCI-G97-1141

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Under 21 at diagnosis
Sponsor: NCI, Other
Protocol IDs: CDR0000065993, COG-P9720, POG-9720, NCT00003178
1    
New Search